The Health Sciences Authority (HSA) has approved Sanofi and AstraZeneca's BEYFORTUS (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and ...

RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

The New York State Department of Health has updated a standing order, allowing pharmacists to administer the respiratory ...

In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency ...

The American Academy of Pediatrics is splitting from the federal government in its recommendations on which children should ...

No RSV vaccine has been approved by the Food and Drug Administration, but the first attempt was made in the 1960s, which was unsuccessful as it led to severe and lethal cases of lung inflammatory ...

Supply of RSV antibody shot struggling to meet demand Atlanta — Lucas Cerna's mother is getting him a respiratory syncytial virus shot while his pediatrician still has it in stock.

The Centers for Disease Control and Prevention and the Department of Health and Human Services adopted Aug. 4 the Advisory Committee on Immunization Practices’ recommendations for respiratory ...

The primary cohort (to assess the RSV outcome) was comprised of 18,767 children with SARS-CoV-2 infection, 6,697 with ...

For infants born from October to February, maternal vaccination was cost-effective, but compared with vaccination, nirsevimab ...

Manitoba plans to update its RSV immunization program, but the province is not committing to following the majority of Canada ...

Newborn babies whose mother received the RSV vaccination during pregnancy were about 80% less likely to be admitted to ...